These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14054890)

  • 61. [A study of the influence of proteolytic enzymes on various types of Clostridium botulinum toxin].
    Tanaka H
    Nihon Eiseigaku Zasshi; 1970 Aug; 25(3):299-309. PubMed ID: 4921899
    [No Abstract]   [Full Text] [Related]  

  • 62. Natural resistance of irradiated animals to botulin toxins.
    Bulatova TI; Kaulen DR
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(1):67-73. PubMed ID: 5332086
    [No Abstract]   [Full Text] [Related]  

  • 63. [Recent observations on the toxins of Clostridium botulinum, with special reference to type E].
    Sakaguchi G
    Tanpakushitsu Kakusan Koso; 1968 Sep; 13(10):921-8. PubMed ID: 4883374
    [No Abstract]   [Full Text] [Related]  

  • 64. Antigenicity of Clostridium botulinum type-E formol toxoid.
    Kondo H; Kondo S; Murata R; Sakaguchi G
    Jpn J Med Sci Biol; 1969 Apr; 22(2):75-85. PubMed ID: 4899485
    [No Abstract]   [Full Text] [Related]  

  • 65. Susceptibility of mink to Clostridium botulinum type E toxin.
    Skulberg A; Valland M
    Acta Vet Scand; 1969; 10(2):137-45. PubMed ID: 4901228
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography.
    Sakaguchi G; Sakaguchi S; Kozaki S; Sugii S; Oishi I
    Jpn J Med Sci Biol; 1974 Jun; 27(3):161-72. PubMed ID: 4604281
    [No Abstract]   [Full Text] [Related]  

  • 67. [Effect of type B botulinus toxin on the level of pyruvic acid in the tissues of guinea pigs].
    PAK ZP
    Farmakol Toksikol; 1962; 25():614-8. PubMed ID: 13941137
    [No Abstract]   [Full Text] [Related]  

  • 68. [Effect of increased histamine content in mouse tissue on acute toxicity of Botulinus toxin].
    Boras J; Stern P
    Arh Hig Rada Toksikol; 1969; 20(2):161-5. PubMed ID: 4905385
    [No Abstract]   [Full Text] [Related]  

  • 69. Alternatives in testing of bacterial toxins and antitoxins.
    Sesardic D
    Dev Biol (Basel); 2002; 111():101-8. PubMed ID: 12678229
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities.
    Dembek ZF; Smith LA; Rusnak JM
    Disaster Med Public Health Prep; 2007 Nov; 1(2):122-34. PubMed ID: 18388640
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Studies on immunity to toxins of Clostridium botulinum. V. Detoxification of purified type A and type B toxins, and the antigenicity of univalent and bivalent aluminium phosphate adsorbed toxoids.
    WRIGHT GG; DUFF JT; FIOCK MA; DEVLIN HB; SODERSTROM RL
    J Immunol; 1960 Apr; 84():384-9. PubMed ID: 13846070
    [No Abstract]   [Full Text] [Related]  

  • 72. Toxin production in Clostridium botulinum as demonstrated by electron microscopy.
    Duda JJ; Slack JM
    J Bacteriol; 1969 Feb; 97(2):900-4. PubMed ID: 4886298
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Isolation of Clostridium botulinum type E from Cayuga Lake fish.
    Chapman HM; Naylor HB
    Appl Microbiol; 1966 Mar; 14(2):301-2. PubMed ID: 5335389
    [No Abstract]   [Full Text] [Related]  

  • 74. Physiological studies on Clostridium botulinum, type F. ORO-3347-7.
    Walls NW
    ORO Rep; 1966 Jan; ():1-9. PubMed ID: 4905225
    [No Abstract]   [Full Text] [Related]  

  • 75. A study of Clostridium botulinum toxoids. I. Type A Clostridium botulinum toxoid.
    VOROB'EV AA; VASIL'EV NN; PATRIKEYEV GT; ZYBIN VD; SHMELEV VM; KORNEV IS; ANAN'EVA EP
    Zh Mikrobiol Epidemiol Immunobiol; 1961; 32():1601-8. PubMed ID: 14040099
    [No Abstract]   [Full Text] [Related]  

  • 76. [Toxigenicity of Clostridium botulinum. 2. Correlation between toxigenicity and sporulating potency].
    Yamagishi T; Kawai Y
    Igaku To Seibutsugaku; 1966 Oct; 73(4):219-23. PubMed ID: 5342036
    [No Abstract]   [Full Text] [Related]  

  • 77. [Study of soluble antigens of type E Clostridium botulinum by gel diffusion].
    Rymkiewicz D; Albrycht H
    Med Dosw Mikrobiol; 1965; 17(4):291-7. PubMed ID: 4956463
    [No Abstract]   [Full Text] [Related]  

  • 78. [The leukotoxin of clostridium botulinum].
    Sytnyk IO
    Mikrobiol Zh; 1969; 31(6):633-7. PubMed ID: 4931210
    [No Abstract]   [Full Text] [Related]  

  • 79. [Lipase and tweenase activity of Cl. perfringens and Cl. botulinum].
    Blagoveshchenskiĭ VA; Tikhaze AK; Borishpolets ZI
    Biull Eksp Biol Med; 1972 Aug; 73(8):74-7. PubMed ID: 4344071
    [No Abstract]   [Full Text] [Related]  

  • 80. Combined action of tetanus and botulinum toxins in animals.
    Kowarzyk H; Czerchawski L; Fal W
    Arch Immunol Ther Exp (Warsz); 1965; 13(4):426-39. PubMed ID: 5320767
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.